News
Outstanding patient retention and clinical execution in complementary AXPAXLI™ SOL trials for wet AMD SOL-1 remains on track for 1Q 2026 topline data SOL-R rescue criteria streamlined and simplified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback